Health economic aspects of minimally invasive surgical techniques
Abstract
The aim of this thesis was to compare minimally invasive- with traditional open
surgical techniques for various diseases with regards to cost-effectiveness. Health
economic evaluations were performed using data from clinical trials and routine care
data from registers. The healthcare perspective was represented in all four studies and
the societal perspective (including sick-leave costs) was represented in three out of
four studies.
Paper I included a cost-minimization analysis of laparoscopic and open surgery as
treatment for rectal cancer within the randomized, controlled COLOR II trial. From
the healthcare perspective laparoscopic surgery was costlier while from the societal
perspective no significant long-term difference was observed. Paper II included a cost
analysis of laparoscopic lavage versus Hartmann’s procedure as treatment for
complicated diverticulitis with purulent peritonitis within the randomized, controlled
DILALA trial. Laparoscopic lavage was considered less costly both at 12 months and
throughout patients’ expected life, from the healthcare perspective. Paper III was a cost
analysis of robot-assisted laparoscopic prostatectomy (RALP) versus open surgery for
prostate cancer within the prospective trial LAPPRO. RALP was associated with a
higher mean cost than open surgery from both the healthcare and societal perspective
at 24 months. Paper IV was a prospective cohort study of cost-effectiveness for
laparoscopic versus open surgery as treatment for colorectal cancer, with resource use
data and unit costs derived from Swedish national registers. Laparoscopic surgery was
associated with better clinical and cost outcomes from both healthcare and societal
perspectives at 12 months after primary surgery.
Minimally invasive surgery can be cost saving compared to conventional open surgery.
It is advisable to perform economic evaluations in routine care, as cost-effectiveness
of surgical techniques most likely will change over time.
Parts of work
I. Health economic analysis of costs of laparoscopic and open surgery for rectal cancer within a randomized trial (COLOR II). Gehrman J, Björholt I, Angenete E, Andersson J, Bonjer J, Haglind E. Surgical endoscopy 2017;31:1225-34. ::doi::10.1007/s00464-016-5096-2 II. Health economic analysis of laparoscopic lavage versus Hartmann's procedure for diverticulitis in the randomized DILALA trial. Gehrman J, Angenete E, Björholt I, Bock D, Rosenberg J, Haglind E. The British journal of surgery 2016;103:1539-47. ::doi::10.1002/bjs.10230 III. Health economic analysis of open and robot-assisted laparoscopic surgery for prostate cancer within the prospective multi-centre LAPPRO trial. Forsmark A, Gehrman J, Angenete E, Bjartell A, Björholt I, Carlsson S, Hugosson J, Marlow T, Stinesen-Kollberg K, Stranne J, Wallerstedt A, Wiklund P, Wilderäng U, Haglind E. Submitted manuscript IV. Laparoscopic surgery was associated with fewer complications and lower costs in routine Swedish care. Gehrman J, Angenete A, Björholt I, Lesén E, Haglind E. Manuscript
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Clinical Sciences. Department of Surgery
Disputation
kl. 9.00, Humlen, Servicehuset, Östra Sjukhuset, Göteborg.
Date of defence
2018-05-18
jacob.gehrman@gu.se
Date
2018-04-25Author
Gehrman, Jacob
Keywords
Minimally invasive surgery
Health economic evaluation
register-based
trial-based
diverticulitis
colorectal cancer
prostate cancer
Publication type
Doctoral thesis
ISBN
978-91-629-0504-0 (PDF)
978-91-629-0503-3 (Print)
Language
eng